Trial · NCT00670748
Adverse events204
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 204
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hemoglobin | Blood and lymphatic system disorders | #1 Anti-NY-ESO-1 TCR PBL+HD IL-2 Mel/RCC | 15 | 17 | 15 |
| other | Hemoglobin | Blood and lymphatic system disorders | #2 Anti-NY-ESO-1 TCR PBL+HD IL-2 OtherCa | 14 | 16 | 14 |
| other | Hemoglobin | Blood and lymphatic system disorders | #3ESO1 TCR PBL+ALVAC ESO1+HD IL2 Mel/RCC | 4 | 7 | 4 |
| other | Hemoglobin | Blood and lymphatic system disorders | #4ESO1 TCR PBL+ALVAC ESO1+HD IL2 OtherCa | 4 | 5 | 4 |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | #1 Anti-NY-ESO-1 TCR PBL+HD IL-2 Mel/RCC | 17 | 17 | 17 |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | #2 Anti-NY-ESO-1 TCR PBL+HD IL-2 OtherCa | 16 | 16 | 16 |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | #3ESO1 TCR PBL+ALVAC ESO1+HD IL2 Mel/RCC | 7 | 7 | 7 |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | #4ESO1 TCR PBL+ALVAC ESO1+HD IL2 OtherCa | 5 | 5 | 5 |
| other | Lymphopenia | Blood and lymphatic system disorders | #1 Anti-NY-ESO-1 TCR PBL+HD IL-2 Mel/RCC | 17 | 17 | 17 |
| other | Lymphopenia | Blood and lymphatic system disorders | #2 Anti-NY-ESO-1 TCR PBL+HD IL-2 OtherCa | 16 | 16 | 16 |
| other | Lymphopenia | Blood and lymphatic system disorders | #3ESO1 TCR PBL+ALVAC ESO1+HD IL2 Mel/RCC | 7 | 7 | 7 |
| other | Lymphopenia | Blood and lymphatic system disorders | #4ESO1 TCR PBL+ALVAC ESO1+HD IL2 OtherCa | 5 | 5 | 5 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | #1 Anti-NY-ESO-1 TCR PBL+HD IL-2 Mel/RCC | 17 | 17 | 17 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | #2 Anti-NY-ESO-1 TCR PBL+HD IL-2 OtherCa | 16 | 16 | 16 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | #3ESO1 TCR PBL+ALVAC ESO1+HD IL2 Mel/RCC | 7 | 7 | 7 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | #4ESO1 TCR PBL+ALVAC ESO1+HD IL2 OtherCa | 5 | 5 | 5 |
| other | Platelets | Blood and lymphatic system disorders | #1 Anti-NY-ESO-1 TCR PBL+HD IL-2 Mel/RCC | 14 | 17 | 14 |
| other | Platelets | Blood and lymphatic system disorders | #2 Anti-NY-ESO-1 TCR PBL+HD IL-2 OtherCa | 16 | 16 | 16 |
| other | Platelets | Blood and lymphatic system disorders | #3ESO1 TCR PBL+ALVAC ESO1+HD IL2 Mel/RCC | 6 | 7 | 6 |
| other | Platelets | Blood and lymphatic system disorders | #4ESO1 TCR PBL+ALVAC ESO1+HD IL2 OtherCa | 5 | 5 | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00670748/events